New York State Teachers Retirement System lowered its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 9.6% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 571,629 shares of the pharmacy operator's stock after selling 60,808 shares during the quarter. New York State Teachers Retirement System owned 0.07% of Walgreens Boots Alliance worth $6,385,000 at the end of the most recent quarter.
Several other institutional investors also recently modified their holdings of WBA. KBC Group NV raised its holdings in shares of Walgreens Boots Alliance by 111.0% during the first quarter. KBC Group NV now owns 131,037 shares of the pharmacy operator's stock valued at $1,463,000 after acquiring an additional 68,933 shares in the last quarter. Allspring Global Investments Holdings LLC lifted its position in shares of Walgreens Boots Alliance by 3.3% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 42,332 shares of the pharmacy operator's stock valued at $472,000 after buying an additional 1,341 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. lifted its stake in shares of Walgreens Boots Alliance by 6.0% during the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 87,428 shares of the pharmacy operator's stock valued at $978,000 after buying an additional 4,926 shares in the last quarter. Achmea Investment Management B.V. grew its position in shares of Walgreens Boots Alliance by 42.5% during the first quarter. Achmea Investment Management B.V. now owns 348,130 shares of the pharmacy operator's stock worth $3,889,000 after purchasing an additional 103,857 shares in the last quarter. Finally, Bessemer Group Inc. lifted its holdings in shares of Walgreens Boots Alliance by 106.9% in the first quarter. Bessemer Group Inc. now owns 35,013 shares of the pharmacy operator's stock worth $390,000 after buying an additional 18,088 shares in the last quarter. 58.59% of the stock is owned by institutional investors.
Walgreens Boots Alliance Stock Performance
Shares of NASDAQ:WBA traded up $0.02 on Monday, reaching $11.49. The company's stock had a trading volume of 1,642,058 shares, compared to its average volume of 17,675,029. Walgreens Boots Alliance, Inc. has a 52-week low of $8.08 and a 52-week high of $13.25. The stock's 50-day moving average is $11.26 and its two-hundred day moving average is $10.90. The company has a debt-to-equity ratio of 0.96, a current ratio of 0.60 and a quick ratio of 0.32. The stock has a market capitalization of $9.94 billion, a P/E ratio of -1.58, a PEG ratio of 1.35 and a beta of 0.78.
Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last posted its quarterly earnings results on Thursday, June 26th. The pharmacy operator reported $0.38 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.34 by $0.04. The company had revenue of $38.99 billion during the quarter, compared to the consensus estimate of $36.72 billion. Walgreens Boots Alliance had a negative net margin of 4.07% and a positive return on equity of 17.66%. The company's revenue for the quarter was up 7.2% on a year-over-year basis. During the same period last year, the firm earned $0.63 EPS. As a group, sell-side analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current year.
Analyst Upgrades and Downgrades
WBA has been the subject of several recent research reports. UBS Group reiterated a "neutral" rating on shares of Walgreens Boots Alliance in a research report on Thursday, June 26th. Wall Street Zen initiated coverage on Walgreens Boots Alliance in a report on Wednesday, May 21st. They issued a "hold" rating for the company. Finally, Morgan Stanley reaffirmed an "underweight" rating on shares of Walgreens Boots Alliance in a research report on Thursday, June 26th. Four research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have issued a buy rating to the company. According to MarketBeat.com, Walgreens Boots Alliance has an average rating of "Hold" and an average price target of $10.59.
View Our Latest Report on WBA
Insiders Place Their Bets
In other Walgreens Boots Alliance news, Chairman Stefano Pessina acquired 832,258 shares of the company's stock in a transaction dated Sunday, April 27th. The stock was acquired at an average cost of $11.01 per share, with a total value of $9,163,160.58. Following the purchase, the chairman directly owned 145,621,079 shares in the company, valued at approximately $1,603,288,079.79. This trade represents a 0.57% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this link. Company insiders own 17.50% of the company's stock.
Walgreens Boots Alliance Company Profile
(
Free Report)
Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
Further Reading

Before you consider Walgreens Boots Alliance, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Walgreens Boots Alliance wasn't on the list.
While Walgreens Boots Alliance currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.